Selective reduction of adrenal medulla response to angiotensin induced by suppression of renin-angiotensin.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 393522)

Published in Eur J Pharmacol on November 16, 1979

Authors

M Mazur-Ruder, G Feuerstein, D Roll, Y Gutman

Articles by these authors

Behavioral engineering: postural control by a portable operant apparatus. J Appl Behav Anal (1968) 2.65

Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab (1996) 1.99

Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther (1992) 1.72

Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci (1981) 1.55

The value of USP public standards for therapeutic products. Pharm Res (2004) 1.54

Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma. Mol Pathol (1998) 1.52

Adenosine triphosphate stimulates inositol phospholipid metabolism and prostacyclin formation in adrenal medullary endothelial cells by means of P2-purinergic receptors. Proc Natl Acad Sci U S A (1987) 1.48

A new salutary resuscitative fluid: liposome encapsulated hemoglobin/hypertonic saline solution. J Trauma (1993) 1.42

Intrinsic GABAergic system of adrenal chromaffin cells. Proc Natl Acad Sci U S A (1984) 1.20

Polydipsia induced by isoprenaline and by lithium: relation to kidneys and renin. Eur J Pharmacol (1972) 1.20

Breathing 100% oxygen after global brain ischemia in Mongolian Gerbils results in increased lipid peroxidation and increased mortality. Stroke (1987) 1.12

Phosphorylation of purified Novikoff hepatoma topoisomerase I. Biochem Biophys Res Commun (1983) 1.10

Prostacyclin reversal of lethal endotoxemia in dogs. J Clin Invest (1981) 1.05

Fire safety training with adults who are profoundly mentally retarded. Ment Retard (1985) 1.00

ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. J Appl Physiol (1985) (1993) 0.98

Renin-angiotensin mediation of adrenal catecholamine secretion induced by haemorrhage. Eur J Pharmacol (1977) 0.98

The differential effect of Li + on microsomal ATPase in cortex, medulla and papilla of the rat kidney. Biochim Biophys Acta (1973) 0.98

Vascular effects of lipopolysaccharide are enhanced in interleukin-10-deficient mice. Stroke (1999) 0.98

Prostaglandins, leukotrienes, and platelet-activating factor in shock. Annu Rev Pharmacol Toxicol (1987) 0.98

The influence of cold or isolation stress on neuroinvasiveness and virulence of an attenuated variant of West Nile virus. Arch Virol (1989) 0.97

Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock. Circ Res (1991) 0.97

Stroke risk factors prepare rat brainstem tissues for modified local Shwartzman reaction. Stroke (1988) 0.95

Role of complement in endotoxin/platelet-activating factor-induced lung injury. J Immunol (1992) 0.93

Leukotrienes and the cardiovascular system. Prostaglandins (1984) 0.92

Neuroprotective effects of SKF 10,047 in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke (1992) 0.92

An improved clinically relevant sepsis model in the conscious rat. Crit Care Med (2000) 0.92

Voltage-sensitive calcium flux into bovine chromaffin cells occurs through dihydropyridine-sensitive and dihydropyridine- and omega-conotoxin-insensitive pathways. Neuroscience (1989) 0.92

Preferential secretion of adrenaline or noradrenaline by the cat adrenal in vivo in response to different stimuli. Br J Pharmacol (1971) 0.92

Hypothalamic sites for cardiovascular and sympathetic modulation by prostaglandin E2. Brain Res (1982) 0.91

Inhibition by PGE2 and by phenylephrine of catecholamine release from human adrenal in vitro. Eur J Pharmacol (1977) 0.91

Quantitation of perivascular monocytes and macrophages around cerebral blood vessels of hypertensive and aged rats. J Cereb Blood Flow Metab (1994) 0.91

Mu-receptors mediate opioid cardiovascular effects at anterior hypothalamic sites through sympatho-adrenomedullary and parasympathetic pathways. Endocrinology (1983) 0.90

Effects of PAF and BN 52021 on cardiac function and regional blood flow in conscious rats. Am J Physiol (1989) 0.90

Acetylcholine and cAMP in adrenal medulla:indirect effect. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.90

Effect of platelet-activating factor on coronary circulation of the domestic pig. Am J Physiol (1984) 0.90

Vasopressin: an essential pressor factor for blood pressure recovery following hemorrhage. Peptides (1982) 0.90

Angiotensin increases microsomal (Na + -K + )-ATPase activity in several tissues. Biochim Biophys Acta (1972) 0.89

Cardiovascular effects of rat calcitonin gene-related peptide in the conscious rat. J Pharmacol Exp Ther (1988) 0.89

Deteriorating stroke model: histopathology, edema, and eicosanoid changes following spinal cord ischemia in rabbits. Stroke (1987) 0.89

Liposome-encapsulated hemoglobin: an oxygen-carrying fluid. Circ Shock (1990) 0.88

Blood flow and vascular permeability during motor dysfunction in a rabbit model of spinal cord ischemia. Stroke (1992) 0.88

Alpha-adrenergic stimulants, prostaglandins and catecholamine release from the adrenal gland in vitro. Prostaglandins (1975) 0.88

Platelet-activating factor in stroke and brain injury. Ann Neurol (1991) 0.88

Inhibitory effect of new PAF antagonists on PAF-induced rabbit platelet aggregation in vitro and ex vivo. J Lipid Mediat (1992) 0.87

Suppression by noradrenaline of catecholamine secretion from adrenal medulla. Eur J Pharmacol (1974) 0.87

Purification and characterization of a nuclear DNA-binding phosphoprotein in fetal and tumor tissues. Cancer Res (1981) 0.87

Validation of laser-Doppler flowmetry in measurement of spinal cord blood flow. Am J Physiol (1989) 0.86

Liver N-demethylating activity--temperature effect and phenobarbital induction in different species. Biochem Pharmacol (1971) 0.86

Increased catecholamine release from adrenal medulla by liposomes loaded with sodium or calcium ions. Biochem Pharmacol (1979) 0.86

The opioid peptides. A role in hypertension? Hypertension (1987) 0.86

mu Receptors and opioid cardiovascular effects in the NTS of rat. Peptides (1983) 0.86

Blood rheology in acute myocardial infarction: effects of high-dose i.v. streptokinase compared to placebo. Eur Heart J (1992) 0.86

Hypothalamic regulation of the cardiovascular and respiratory systems: role of specific opiate receptors. Br J Pharmacol (1983) 0.86

Prominent white matter lesions develop in Mongolian gerbils treated with 100% normobaric oxygen after global brain ischemia. Acta Neuropathol (1990) 0.86

Identification of endothelin receptors in various regions of rat brain. Neuropeptides (1990) 0.86

Tumor necrosis factor-alpha mediates endotoxin-induced lung injury in platelet activating factor-primed rats. J Pharmacol Exp Ther (1993) 0.86

Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumours. Br J Cancer (2011) 0.85

Opiate binding in rat hearts: modulation of binding after hemorrhagic shock. Biochem Biophys Res Commun (1985) 0.85

Neuroprotective effects of phenyl-t-butyl-nitrone in gerbil global brain ischemia and in cultured rat cerebellar neurons. Brain Res (1992) 0.85

Water intake of rats after implantation of ouabain into the hypothalamus. Am J Physiol (1967) 0.85

Coronary constriction by leukotriene C4, D4, and E4 in the intact pig heart. Am J Cardiol (1983) 0.85

Effects of verapamil, dantrolene and lanthanum on catecholamine release from rat adrenal medulla. Br J Pharmacol (1979) 0.85

Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist. J Pharmacol Exp Ther (1990) 0.85

PGE2: opposite effect on catecholamine release from phaeochromocytoma and adrenal medulla. Prostaglandins (1976) 0.85

Differential cardiovascular effects of mu, delta and kappa opiate agonists at discrete hypothalamic sites in the anesthetized rat. Life Sci (1983) 0.85

Postischemic production of eicosanoids in gerbil brain. Stroke (1987) 0.85

Cardiac and coronary consequences of intracoronary platelet activating factor infusion in the domestic pig. Prostaglandins (1987) 0.85

Neuroprotective effects of tetrodotoxin as a Na+ channel modulator and glutamate release inhibitor in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke (1994) 0.84

Evidence for platelet-activating factor as a novel mediator in experimental stroke in rabbits. Stroke (1990) 0.84

Evidence for activation of endothelium and monocytes in hypertensive rats. Am J Physiol (1996) 0.84

Haloperidol-induced torsades de pointes. Chest (1990) 0.84

Potent, selective, orally active 3-oxo-1,4-benzodiazepine GPIIb/IIIa integrin antagonists. J Med Chem (1996) 0.84

Grand multiparity: an obstetric or neonatal risk factor? Am J Obstet Gynecol (1988) 0.84

Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils. Eur J Pharmacol (1992) 0.84

Effect of endothelin on cortical microvascular perfusion in rats. Stroke (1990) 0.84

Dehydroepiandrosterone protects mice inoculated with West Nile virus and exposed to cold stress. J Med Virol (1992) 0.83

Subcellular distribution of noradrenaline after cold exposure. Br J Pharmacol Chemother (1967) 0.83

Protective effect of BN 50739, a new platelet-activating factor antagonist, in endotoxin-treated rabbits. J Pharmacol Exp Ther (1990) 0.83

Dopamine partially mediates the cardiovascular effects of naloxone after spinal injury. Brain Res (1981) 0.83

An interactive microcomputer program for calculation of combined parenteral and enteral nutrition for neonates. J Pediatr Gastroenterol Nutr (1983) 0.83

Locally produced tumor necrosis factor-alpha mediates interleukin-2-induced lung injury. Circ Res (1996) 0.82

Endothelin and heart failure. Heart Fail Rev (2001) 0.82

Methionine and leucine enkephalin in rat neurohypophysis: different responses to osmotic stimuli and T2 toxin. Science (1985) 0.82

Serum tumor necrosis factor-alpha profile in trauma patients. J Trauma (1993) 0.82

Chinchilla laniger--discrepancy between concentrating ability and kidney structure. Life Sci (1970) 0.82

Antidiuretic hormone and renin in rats with diabetes insipidus. Eur J Pharmacol (1974) 0.82

mu-Opioid receptors in NTS elicit pressor responses via sympathetic pathways. Am J Physiol (1987) 0.82

Mechanism of insulin-induced activation of Na(+)-K(+)-ATPase in isolated rat soleus muscle. Am J Physiol (1991) 0.81

CGRP stimulates the adhesion of leukocytes to vascular endothelial cells. Peptides (1992) 0.81

Evidence for an involvement of mu-, but not delta- or kappa-opiate receptors in sympathetically and parasympathetically mediated cardiovascular responses to opiates upon anterior hypothalamic injection. Life Sci (1983) 0.81

Platelets stimulate expression of endothelin mRNA and endothelin biosynthesis in cultured endothelial cells. Circ Res (1991) 0.81

Effect of an increase and of lack of antidiuretic hormone on plasma renin activity in the rat. Life Sci I (1971) 0.81

Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670. J Pharmacol Exp Ther (1994) 0.81

Selective cardiorespiratory effects mediated by mu opioid receptors in the nucleus ambiguus. Neuropharmacology (1984) 0.81

Hemodynamic and neural mechanisms of action of thyrotropin-releasing hormone in the rat. Circ Res (1988) 0.81

Interleukin-1 beta (IL-1 beta) induces transforming growth factor-beta, (TGF-beta 1) production by rat aortic smooth muscle cells. Biochem Biophys Res Commun (1994) 0.81

Aspiration-induced lung injury: role of complement. Crit Care Med (1995) 0.81

Expression and translocation of the chlamydial major outer membrane protein in Escherichia coli. Microb Pathog (1993) 0.81

Effect of indomethacin on the blood pressure and plasma catecholamine responses to acute endotoxaemia. J Pharm Pharmacol (1981) 0.81